HighPoint Advisor Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $386K | Sell |
4,929
-819
| -14% | -$66.1K | 0.01% | 524 |
|
|
2026
Q1 | $498K | Sell |
5,748
-32,769
| -85% | -$3.14M | 0.02% | 426 |
|
|
2025
Q4 | $3.7M | Buy |
38,517
+8,031
| +26% | +$780K | 0.08% | 217 |
|
|
2025
Q3 | $2.9M | Buy |
30,486
+3,257
| +12% | +$299K | 0.14% | 125 |
|
|
2025
Q2 | $2.37M | Buy |
27,229
+510
| +2% | +$43.3K | 0.13% | 135 |
|
|
2025
Q1 | $2.26M | Buy |
26,719
+735
| +3% | +$65.8K | 0.13% | 129 |
|
|
2024
Q4 | $2.34M | Buy |
25,984
+983
| +4% | +$85.1K | 0.13% | 135 |
|
|
2024
Q3 | $2.25M | Sell |
25,001
-2,922
| -10% | -$246K | 0.13% | 130 |
|
|
2024
Q2 | $2.26M | Buy |
27,923
+15,670
| +128% | +$1.28M | 0.13% | 128 |
|
|
2024
Q1 | $1.02M | Sell |
12,253
-235
| -2% | -$20.1K | 0.07% | 218 |
|
|
2023
Q4 | $1.04M | Buy |
+12,488
| New | +$952K | 0.07% | 213 |
|
|
2022
Q2 | $1.14M | Buy |
+12,698
| New | +$1.29M | 0.12% | 132 |
|
|
2021
Q3 | $1.75M | Buy |
13,970
+549
| +4% | +$71.1K | 0.17% | 111 |
|
|
2021
Q2 | $1.67M | Buy |
13,421
+3,611
| +37% | +$453K | 0.17% | 117 |
|
|
2021
Q1 | $1.2M | Buy |
9,810
+1,895
| +24% | +$222K | 0.14% | 126 |
|
|
2020
Q4 | $933K | Buy |
7,915
+589
| +8% | +$64.8K | 0.11% | 152 |
|
|
2020
Q3 | $762K | Buy |
7,326
+1,164
| +19% | +$117K | 0.14% | 129 |
|
|
2020
Q2 | $569K | Sell |
6,162
-228
| -4% | -$21.9K | 0.12% | 148 |
|
|
2020
Q1 | $634K | Sell |
6,390
-569
| -8% | -$60.5K | 0.15% | 118 |
|
|
2019
Q4 | $837K | Buy |
6,959
+766
| +12% | +$84.1K | 0.17% | 109 |
|
|
2019
Q3 | $662K | Buy |
6,193
+992
| +19% | +$104K | 0.15% | 124 |
|
|
2019
Q2 | $526K | Buy |
5,201
+156
| +3% | +$14.2K | 0.12% | 145 |
|
|
2019
Q1 | $450K | Sell |
5,045
-8,415
| -63% | -$753K | 0.11% | 171 |
|
|
2018
Q4 | $1.24M | Buy |
13,460
+1,165
| +9% | +$109K | 0.33% | 70 |
|
|
2018
Q3 | $1.15M | Buy |
12,295
+8,031
| +188% | +$742K | 0.32% | 71 |
|
|
2018
Q2 | $388K | Sell |
4,264
-89
| -2% | -$7.43K | 0.1% | 203 |
|
|
2018
Q1 | $379K | Buy |
4,353
+740
| +20% | +$61K | 0.1% | 202 |
|
|
2017
Q4 | $290K | Sell |
3,613
-523
| -13% | -$41.9K | 0.08% | 226 |
|
|
2017
Q3 | $322K | Buy |
4,136
+919
| +29% | +$76.3K | 0.1% | 202 |
|
|
2017
Q2 | $269K | Hold |
3,217
| – | – | 0.09% | 224 |
|
|
2017
Q1 | $269K | Sell |
3,217
-676
| -17% | -$52.8K | 0.09% | 224 |
|
|
2016
Q4 | $320K | Sell |
3,893
-2,402
| -38% | -$189K | 0.1% | 212 |
|
|
2016
Q3 | $515K | Sell |
6,295
-4,215
| -40% | -$367K | 0.18% | 146 |
|
|
2016
Q2 | $922K | Buy |
10,510
+713
| +7% | +$57.7K | 0.32% | 80 |
|
|
2016
Q1 | $774K | Sell |
9,797
-5,876
| -37% | -$443K | 0.47% | 58 |
|
|
2015
Q4 | $1.19M | Buy |
15,673
+3,222
| +26% | +$243K | 0.78% | 29 |
|
|
2015
Q3 | $833K | Buy |
+12,451
| New | +$917K | 0.92% | 34 |
|
Other funds holding MDT
HighPoint Advisor Group's MDT Position: Q2 2026 in Review
HighPoint Advisor Group reduced its Medtronic (MDT) stake by 14% in Q2 2026, selling an estimated $66.1K and leaving 4,929 shares worth $386K. The position accounts for 0.01% of the portfolio, ranked #524.
HighPoint Advisor Group first reported a position in MDT in Q3 2015 and has held it in 37 quarters since. The position peaked at $3.7M in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- HighPoint Advisor Group held 4,929 shares of Medtronic worth $386K as of Q2 2026.
- HighPoint Advisor Group sold 819 Medtronic shares in Q2 2026, an estimated $66.1K.
- Medtronic made up 0.01% of HighPoint Advisor Group's portfolio in Q2 2026, its #524 holding.
- HighPoint Advisor Group first reported a position in Medtronic in Q3 2015 and has held it in 37 quarters since.
- HighPoint Advisor Group's Medtronic position peaked at $3.7M in Q4 2025.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on HighPoint Advisor Group's 13F filing for Q2 2026, filed 5 Aug 2026.